Gamble Jones Investment Counsel Abb Vie Inc. Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Abb Vie Inc. stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 96,205 shares of ABBV stock, worth $16.6 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

96,205

Previous 96,350 0.15%

Holding current value

$16.6 Million

Previous $12.9 Million 20.31%

% of portfolio

1.17%

Previous 1.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $20,054 - $24,051	-145 Reduced 0.15%	96,205 $15.6 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $448,798 - $514,741	-3,344 Reduced 3.35%	96,350 $12.9 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $1.02 Million - $1.29 Million	-7,387 Reduced 6.9%	99,694 $15.3 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $240,731 - $298,680	-1,824 Reduced 1.67%	107,081 $17.4 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $74,126 - $93,791	-690 Reduced 0.63%	108,905 $14.7 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $675,852 - $767,194	-6,352 Reduced 5.48%	109,595 $11.8 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $252,398 - $281,186	-2,399 Reduced 2.03%	115,947 $13.1 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $193,040 - $212,513	-1,887 Reduced 1.57%	118,346 $12.8 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $717,326 - $968,467	-8,912 Reduced 6.9%	120,233 $12.9 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $18,642 - $21,880	217 Added 0.17%	129,145 $11.3 Million
Q2 2020 Aug 19, 2020	SELL	$73.37 - $98.18 $83,861 - $112,219	-1,143 Reduced 0.88%	128,928 $12.7 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $187,630 - $284,471	-2,909 Reduced 2.19%	130,071 $9.91 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $220,573 - $275,984	3,058 Added 2.35%	132,980 $11.8 Million
Q3 2019 Nov 04, 2019	SELL	$62.98 - $75.72 $566,001 - $680,495	-8,987 Reduced 6.47%	129,922 $9.84 Million
Q2 2019 Aug 20, 2019	SELL	$65.7 - $83.98 $474,551 - $606,587	-7,223 Reduced 4.94%	138,909 $10.1 Million
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $160,914 - $189,387	-2,086 Reduced 1.41%	146,132 $11.8 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $494,814 - $610,239	-6,356 Reduced 4.11%	148,218 $13.7 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $436,370 - $485,106	-4,908 Reduced 3.08%	154,574 $14.6 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $259,643 - $307,217	-2,892 Reduced 1.78%	159,482 $14.8 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $395,827 - $530,049	-4,302 Reduced 2.58%	162,374 $15.4 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $2.94 Million - $3.22 Million	-32,788 Reduced 16.44%	166,676 $16.1 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $13.9 Million - $17.8 Million	199,464	199,464 $17.7 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Abb Vie Inc. Transaction History